WRBY,Warby Parker Inc. | Healthcare

Healthcare

WRBY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Warby Parker Inc.WRBY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

1.79B

Revenue (ttm)

771.32M

Net Income (ttm)

-20.39M

Shares Out

120.86M

EPS (ttm)

-0.17

PE Ratio

n/a

Forward PE

43.73

Dividend

n/a

Ex-Dividend Date

n/a

Volume

1,294,804

Open

14.80

Previous Close

15.17

Day's Range

13.94 - 14.96

52-Week Range

11.66 - 28.68

Beta

2.01

Analysts

Buy

Price Target

23.69 (+60.34%)

Earnings Date

May 8, 2025

Description >

Warby Parker Inc. provides eyewear products. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses.

It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps.

In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Latest News >

Energy Capital Partners to acquire Atlantica for $2.56 bln

May 28, 2024

May 28 (Reuters) - Private equity firm Energy Capital Partners will buy Atlantica Sustainable Infrastructure ( AY ) for $2.56 billion in cash, the utility said on Tuesday, in a deal that will give its biggest shareholder funds to lower its debt. Atlantica, which started a strategic review in February last year, will get $22 per share, a near 19%...

Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint

May 28, 2024

07:34 AM EDT, 05/28/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday that a phase 3 trial evaluating Keytruda in combination with chemotherapy as a treatment for patients with high-risk early-stage triple-negative breast cancer met its overall survival endpoint. The trial evaluated the combination therapy as a pre-operative treatment and as a single agent after surgery, Merck ( MRK...

--PayPal Planning to Build Ad Business, The Wall Street Journal Reports

May 28, 2024

07:34 AM EDT, 05/28/2024 (MT Newswires) -- Price: 62.42, Change: +0.78, Percent Change: +1.27 ...

Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge

May 28, 2024

Baozun Inc ( BZUN ) reported a fiscal first-quarter 2024 revenue growth of 4.9% year-on-year to 1.98 billion Chinese yuan ($274.2 million), beating the analyst consensus estimate of $269.6 million. Adjusted loss per ADS was $0.03, compared to the analyst consensus estimate of $0.00. The stock price gained after the results. The increase in total net revenues was mainly due to higher product sales...